PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
12-Feb-2025 Bioxodes secures new funds to reach early 2025 milestones and pursue Series B financing Bioxodes
12-Feb-2025 Ascendis Pharma, a global biopharmaceutical company specialising in rare endocrine and other diseases, opens new office for the UK and Ireland Ascendis Pharma
12-Feb-2025 Lansmont is pleased to announce the appointment of Scott Robinson as its New EMEA Sales Manager Lansmont
11-Feb-2025 JuliaHub Doubles Investment in Advanced Pharmaceutical Modeling Platform JuliaHub
11-Feb-2025 LYNPARZA (OLAPARIB) ACCEPTED FOR USE IN SCOTLAND TO TREAT GERMLINE BRCA-MUTATED HER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER AFTER CHEMOTHERAPY AstraZeneca
11-Feb-2025 ELLIPSES IN-LICENCES FIRST IN CLASS NOVEL IMMUNO-ONCOLOGY AGENT WITH POTENTIAL AS A NEXT GENERATION CHECKPOINT INHIBITOR Ellipses Pharma Limited
11-Feb-2025 ENA Respiratory Receives US$5m Investment from Flu Lab to Support Clinical Development of Novel Intranasal Antiviral Host Defence Immune Enhancer, INNA-051 ENA Respiratory
11-Feb-2025 Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month Mainz BioMed N.V.
11-Feb-2025 Original-Research: Sernova Biotherapeutics Inc (von First Berlin Equity Research GmbH) Sernova Biotherapeutics Inc
11-Feb-2025 Domino to Showcase GS1 QR Code Implementation at GS1 Global Forum 2025 Domino Printing Sciences
11-Feb-2025 VERSION 1 AWARDED NATIONAL CONTRACT TO SUPPORT HEALTH SERVICE EXECUTIVE (HSE) IN DELIVERING DIGITALLY ENABLED HEALTH AND SOCIAL CARE SERVICES ACROSS IRELAND Version 1
11-Feb-2025 Glox Therapeutics Strengthens Team Appointing Dr Michael Murray as Chair and Dr Nel Moore as Scientific Advisory Board Member Glox Therapeutics
11-Feb-2025 Reef Group and BlackRock Real Estate complete first laboratory building at London’s largest purpose-built life sciences campus Reef Group
11-Feb-2025 Moberg Pharma Year-end report 2024 Moberg Pharma
11-Feb-2025 Glox Therapeutics Strengthens Team Appointing Dr Michael Murray as Chair and Dr Nel Moore as Scientific Advisory Board Member Glox Therapeutics
11-Feb-2025 BIOVERSYS SUCCESSFULLY ADVANCES BV500 NTM PROGRAM WITH CONTINUED SUPPORT FROM CF AMR SYNDICATE BioVersys AG
11-Feb-2025 Relief Therapeutics Announces European Patent Office Decision to Grant Patent for RLF-TD011 Relief Therapeutics Holding SA
10-Feb-2025 Qureight and Avalyn Launch Strategic Partnership in Progressive Pulmonary Fibrosis Qureight
10-Feb-2025 Ourvita’s strategic acquisition of Laboratoria Natury Ourvita
10-Feb-2025 LYNPARZA (OLAPARIB) ACCEPTED FOR USE IN SCOTLAND TO TREAT GERMLINE BRCA-MUTATED HER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER AFTER CHEMOTHERAPY AstraZeneca